Arkolith/Insider Trading/AVEO/Form 4

Mayes, Gregory T.

DirectorAVEO PHARMACEUTICALS, INC. (AVEO) · full profile →Form 4 · filed Jan 19, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 19, 2023Disposed to issuer(D)10K——0
Jan 19, 2023Disposed to issuer(D)23K——0
Jan 19, 2023Disposed to issuer(D)13K——0
Jan 19, 2023Disposed to issuer(D)4K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-002184) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML